Summary of Key Points Core Viewpoint - The company, Guosheng Tang, has been actively repurchasing its shares, indicating a strategy to support its stock price amidst a recent decline. Share Buyback Activity - On November 3, Guosheng Tang repurchased 334,400 shares at a price range of HKD 28.120 to HKD 29.260, totaling HKD 9.6716 million. The stock closed at HKD 29.000, up 1.54% on that day, with a total trading volume of HKD 51.0738 million [2]. - Since September 10, the company has conducted share buybacks for 36 consecutive days, acquiring a total of 6.5062 million shares for a cumulative amount of HKD 199 million. During this period, the stock has decreased by 12.89% [2]. - Year-to-date, the company has executed 59 buybacks, totaling 9.4608 million shares and an aggregate buyback amount of HKD 294 million [3]. Detailed Buyback Data - The buyback details for November 3 include: - Shares repurchased: 33.44 million - Highest price: HKD 29.260 - Lowest price: HKD 28.120 - Total amount: HKD 9.6716 million [3]. - A comprehensive table of buyback activities shows various dates, share quantities, highest and lowest prices, and total amounts for each transaction, reflecting a consistent buyback strategy throughout the year [4][5].

Core Viewpoint - The company, Guoshengtang (02273), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 9.6716 million to repurchase 334,400 shares [1]

Core Viewpoint - Gushengtang (02273.HK) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will spend HKD 9.6716 million to repurchase 334,400 shares [1] - The buyback price ranges from HKD 28.12 to HKD 29.26 per share [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 固生堂控股有限公司 呈交日期： 2025年11月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02273 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

Core Viewpoint - On October 31, 33 Hong Kong-listed companies conducted share buybacks, totaling 21.84 million shares and an aggregate amount of HKD 152 million [1][2]. Group 1: Buyback Details - China COSCO Shipping Holdings (中远海控) repurchased 3 million shares for HKD 40.71 million, with a highest price of HKD 13.750 and a lowest price of HKD 13.350, bringing its total buyback amount for the year to HKD 4.447 billion [1][2]. - Guo Sheng Tang (固生堂) repurchased 582,000 shares for HKD 16.59 million, with a highest price of HKD 28.680 and a lowest price of HKD 28.340, totaling HKD 284 million in buybacks for the year [1][2]. - Sinopec Limited (中国石油化工股份) repurchased 3.652 million shares for HKD 15.12 million, with a highest price of HKD 4.170 and a lowest price of HKD 4.110, accumulating HKD 871 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 31 was from China COSCO Shipping Holdings at HKD 40.71 million, followed by Guo Sheng Tang at HKD 16.59 million [1][2]. - In terms of share quantity, Sinopec Limited led with 3.652 million shares repurchased, followed by China COSCO Shipping Holdings with 3 million shares and Linklogis Technology (联易融科技-W) with 2.34 million shares [1][2].

Core Points - The company Gushengtang has been actively repurchasing its shares, with a total of 617,180 shares bought back since September 10, amounting to HKD 190 million [2] - The stock has experienced a cumulative decline of 14.21% during the same period despite the buybacks [2] - In 2023, Gushengtang has conducted 58 repurchase transactions, totaling 9.1264 million shares and an expenditure of HKD 284 million [2] Repurchase Details - On October 31, 2025, Gushengtang repurchased 582,000 shares at a price range of HKD 28.340 to HKD 28.680, with a total expenditure of HKD 16.5874 million [2] - The closing price of the stock on the same day was HKD 28.560, reflecting a slight increase of 0.07% [2] - The highest repurchase price recorded during the recent buyback was HKD 32.700 on September 22, 2025, while the lowest was HKD 28.100 on April 7, 2025 [3][4]

Core Insights - The company, Guoshengtang (02273), reported a total of approximately 1.607 million patient visits for the three months ending September 30, 2025, representing an increase of about 8.2% compared to the same period in 2024 [1] Company Performance - Total patient visits reached approximately 1.607 million [1] - Year-over-year growth in patient visits is approximately 8.2% [1]

Core Viewpoint - The company reported a total of approximately 1.607 million patient visits for the three months ending September 30, 2025, representing an increase of about 8.2% compared to the same period in 2024 [1] Company Summary - The total number of patient visits for the company reached approximately 1.607 million [1] - This figure indicates a growth rate of approximately 8.2% year-over-year [1]

Core Insights - The company, Guoshengtang (02273.HK), reported operational data for the three months ending September 30, 2025, indicating a total of approximately 1.607 million patient visits, which represents an increase of about 8.2% compared to the same period in 2024, where there were approximately 1.485 million patient visits [1] Summary by Category - **Operational Performance** - Total patient visits for the three months ending September 30, 2025, were approximately 1.607 million, reflecting an 8.2% growth year-over-year from approximately 1.485 million visits in 2024 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 GUSHENGTANG HOLDINGS LIMITED 固 生 堂 控 股 有 限 公 司 固生堂控股有限公司 （根據開曼群島法律註冊成立的有限公司） （股份代號：2273） 自願性公告 截至2025年9月30日止三個月之經營數據 本公告乃由固生堂控股有限公司（「本公司」）自願作出，旨在向本公司股東及 有意投資者提供截至2025年9月30日止三個月之本集團最新業務發展。 截至2025年9月30日止三個月的客戶就診人次總數約為1,607,000，較2024年同期 （約1,485,000客戶就診人次）增長約8.2%。 上述經營數據乃基於本公司的記錄，未經本公司核數師審核或審閱。經營數據 可能與相關定期報告所披露者有所不同。如有任何不一致，概以相關定期報告 所披露之經營數據為準。 本公司股東及有意投資者於買賣本公司股份時務請審慎行事。如有任何疑問， 投資者應尋求專業人士或財務顧問的專業意見。 GUSHENG ...